Close Menu

NEW YORK – Solvd Health said on Wednesday that it is preparing to launch a prospective US clinical trial of its noninvasive colorectal cancer screening test, LifeKit Prevent.

The assay is being developed in partnership with Metabiomics, a subsidiary of the Carlsbad, California-based firm. It is an in vitro diagnostic test that uses Metabiomics' MultiTag DNA sequencing technology to detect and analyze microbial genomic biomarkers in human stool samples that are strongly associated with specific stages of CRC progression.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Please join GenomeWeb and Qiagen for an online roundtable discussion where a panel of experts will review challenges and opportunities around genomic variant interpretation workflows in the field of oncology.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.